OLD Category: GeoMx DSP

January 29, 2022 / Trends Immunol

  • Herrera FG, Romero P, Coukos G
January 28, 2022 / Oncogene

  • Saliba J, Coutaud B, Makhani K, Epstein Roth N, Jackson J, Park JY, Gagnon N, Costa P, Jeyakumar T, Bury M, Beauchemin N, Mann KK, Blank V
January 24, 2022 / Cell Rep Med

  • Park J, Foox J, Hether T...Meydan C, Schwartz RE, Mason CE
January 21, 2022 / Cancers

  • Ahmed AA, Farooqi MS, Habeebu SS, Gonzalez E, Flatt TG, Wilson AL, Barr FG
January 20, 2022 / Stem Cell Reports

  • Krasemann S, Haferkamp U, Pfefferle S...Friese MA, Glatzel M, Pless O
January 19, 2022 / Nat Commun

  • Danaher P, Kim Y, Nelson B, Griswold M, Yang Z, Piazza E, Beechem JM
January 17, 2022 / Front Cell Infect Microbiol

  • Glennon EKK, Tongogara T, Primavera VI, Reeder SM, Wei L, Kaushansky A
January 14, 2022 / Clin Cancer Res

  • Arend RC, Scalise CB, Gordon ER, Davis AM, Foxall ME, Johnston BE, Crossman DK, Cooper SJ
January 12, 2022 / Nat Commun

  • Wu H, He P, Ren Y, Xiao S, Wang W, Liu Z, Li H, Wang Z, Zhang D, Cai J, Zhou X, Jiang D, Fei X, Zhao L, Zhang H, Liu Z, Chen R, Li W, Wang C, Zhang S, Qin J, Nashan B, Sun C
January 10, 2022 / Nat Commun

  • Theocharidis G, Thomas BE, Sarkar D...Bhasin SS, Veves A, Bhasin M
January 10, 2022 / Front Oncol

  • Kulasinghe A, Monkman J, Shah ET, Matigian N, Adams MN, O’Byrne K
January 1, 2022 / Engineering Technologies and Clinical Translation (Chapter 11, Academic Press)

  • Fankhauser R, DePatie N, Berryman R, Lucero OM, Kulkarni RP